Cresset Asset Management »

Immunitybio shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $123k 50k 2.46
2025-06-30 $132k 50k 2.64

More positions owned by Cresset Asset Management

Arista Networks Com Shs (ANET)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Erie Indty Cl A (ERIE)
Ishares Tr Core S&p500 Etf (IVV)
Reddit Cl A Put Option (RDDT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core Msci Eafe (IEFA)
Palantir Technologies Cl A Put Option (PLTR)
Ishares Tr Core S&p Scp Etf Put Option (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Put Option (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)

View all positions for Cresset Asset Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
Jane Street
State Street Corporation
Geode Capital Management
Heights Capital Management
Woodline Partners
Susquehanna International
AlphaCore Capital
Morgan Stanley
Two Sigma Investments
Tang Capital Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust

View all funds holding Immunitybio